Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma. - Scalambra, Laura; Ruzzi, Francesca; Pittino, Olga Maria; Semprini, Maria Sofia; Cappello, Chiara; Angelicola, Stefania; Palladini, Arianna; Nanni, Patrizia; Goksøyr, Louise; Fougeroux, Cyrielle; Penichet, Manuel L.; Sander, Adam Frederik; et al. (Journal of Translational Medicine, 2025)